Nature Medicine
| 短名 | Nat Med |
| Journal Impact | 58.82 |
| 国际分区 | MEDICINE, RESEARCH & EXPERIMENTAL(Q1) |
| 期刊索引 | SCI Q1中科院 1 区 |
| ISSN | 1078-8956, 1546-170X |
| h-index | 630 |
| 国内分区 | 医学(1区)医学生化与分子生物学(1区)医学细胞生物学(1区)医学医学研究与实验(1区) |
| Top期刊 | 是 |
NATURE MEDICINE 发表的研究旨在满足当代医学的需求和目标。原始研究范围从人类生物学和疾病发病机制的新概念到新治疗方式和药物开发的强大临床前基础，再到临床工作的所有阶段，以及旨在改善人类健康的创新技术。当前感兴趣的领域还包括但不限于不限于：-基因和细胞疗法-临床基因组学-再生医学-高清医学-环境对人类健康的影响-人工智能在医疗保健中-智能可穿戴设备-早期疾病诊断-微生物组-AGINGNATURE MEDICINE也发表评论、观点和其他内容受其领域的领先科学家委托，以提供推动医学进步的最新研究的专家和背景化观点。新闻部分在编辑上是独立的，并及时及时报道影响医学、研究人员和普通观众的即将到来的趋势。
期刊主页投稿网址| 涉及主题 | 医学生物遗传学内科学化学生物化学病理免疫学基因心理学 |
| 出版信息 | 出版商: Nature Research，出版周期: Monthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1995，原创研究文献占比: 94.47%，自引率:1.00%， Gold OA占比: 47.38% |
| 平均审稿周期 | 网友分享经验：平均1.0个月 |
| 平均录用比例 | 网友分享经验：约15% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial
2024-9-15
Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
2024-9-14
Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
2024-9-14
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial
2024-9-13
Advancing ASO therapies from development to implementation
2024-9-13
Post-approval evidence generation: a shared responsibility for healthcare
2024-9-13
Initiating second-trimester medical abortions at home
2024-9-12
Prenatal exposure to famine affects lifelong health
2024-9-9
Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et al.
2024-9-5
A global metric of immune health
2024-9-5
Cardiovascular safety of vitamin B3 administration
2024-9-5
Niacin, food intake and cardiovascular effects
2024-9-5
Opportunities and challenges for patient-reported outcome assessment in multimorbidity research and practice
2024-9-5
Medicine’s DEI backlash offers an opportunity to refocus on evidence-based approaches
2024-9-5
CAR-T and cellular gene therapies are too expensive
2024-9-4
Hibernation science harnessed to treat obesity and modify metabolism
2024-9-4
Integrating liver endpoints in clinical trials of cardiovascular and kidney disease
2024-9-3
Fratricide-resistant CD7-CAR T cells in T-ALL
2024-9-3
A framework for sharing of clinical and genetic data for precision medicine applications
2024-9-3
A time-stratified, case–crossover study of heat exposure and perinatal mortality from 16 hospitals in sub-Saharan Africa
2024-9-3
Advancing global antibiotic research, development and access
2024-9-3
The WHO genomics program of work for equitable implementation of human genomics for global health
2024-9-3
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells
2024-9-2
Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial
2024-9-2
Senolytics target cellular senescence — but can they slow aging?
2024-9-2
Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART pooled analysis of cardiovascular, kidney, and mortality outcomes
2024-9-1
Digital consults in heart failure care: a randomized controlled trial
2024-8-31
Unidirectional association of clonal hematopoiesis with atherosclerosis development
2024-8-30
Could video games be good for your health?
2024-8-30
Tracking non-relapse mortality after CAR T cell therapy
2024-8-30
Blood lipid profiling indicates that dietary fat quality is associated with cardiometabolic risk
2024-8-30
Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial
2024-8-30
MIDAS: a new platform for quality-graded health data for AI-enabled healthcare in India
2024-8-29
Simplifying obstetric sonography with AI
2024-8-29
Health and economic impacts of Lassa vaccination campaigns in West Africa
2024-8-28
Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
2024-8-28
Author Correction: Targeting the HIF2–VEGF axis in renal cell carcinoma
2024-8-28
Decentralized trial reveals home-testing behaviors for respiratory infections
2024-8-27
Not all AI health tools with regulatory authorization are clinically validated
2024-8-26
A united call for gender equity in global health leadership
2024-8-26
Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations
2024-8-26
Role of anticoagulation therapy in modifying stroke risk associated with new-onset atrial fibrillation after non-cardiac surgery
2024-8-23
Effect of a digital school-based intervention on adolescent family planning and reproductive health in Rwanda: a cluster-randomized trial
2024-8-23
Large language models could make natural language again the universal interface of healthcare
2024-8-23
Discovering and targeting vulnerabilities in invasive brain cancer using ROBO1 CAR T cells
2024-8-23
A community engagement framework to accelerate the uptake of malaria vaccines in Africa
2024-8-22
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
2024-8-21
Mpox is a public health emergency — what happens now?
2024-8-21
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
2024-8-20
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
2024-8-20
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远